Symbols / NLSP
NLSP Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem - PR Newswire Wed, 29 Oct 2025 07
- NLS Pharmaceutics stock tumbles after merger approval with Kadimastem - Investing.com ue, 30 Sep 2025 07
- NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares - PR Newswire Wed, 29 Oct 2025 07
- NLSP Stock Faces Highs and Lows: A Closer Look - StocksToTrade ue, 30 Sep 2025 07
- NLS Pharma (NASDAQ: NLSP): BIRD support continues for ITOL‑102 at NewCelX post‑merger - Stock Titan Wed, 29 Oct 2025 07
- NLS Pharmaceutics and Kadimastem Complete Merger to Form NewcelX - TipRanks hu, 30 Oct 2025 07
- NLS Pharmaceutics: Shares Plummet Amidst New Share Offering - timothysykes.com hu, 23 Oct 2025 07
- NLS Pharmaceutics Expands CNS Pipeline with AEX-6xx Series - TipRanks hu, 30 Oct 2025 07
- NLS Pharma (NASDAQ: NLSP) secures $25M ELOC and $7M to advance AEX-6xx program - Stock Titan hu, 30 Oct 2025 07
- NLS Pharmaceutics announces 1-for-40 reverse stock split - Investing.com Wed, 25 Sep 2024 07
- NLSP Stock Touches 52-Week Low at $2.98 Amid Market Challenges - Investing.com South Africa ue, 03 Dec 2024 08
- NLS Pharmaceutics Announces Merger, FDA Progress for Diabetes Treatment - Stock Titan Mon, 10 Mar 2025 07
- NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split - Stock Titan Wed, 25 Sep 2024 07
- NLSP - Nls Pharmaceutics Ltd Latest Stock News & Market Updates - Stock Titan Fri, 29 Jan 2021 00
- NLS Pharmaceutics AG (NLSP) Stock: Plunges 15% Amid Nasdaq-Approved Merger with Kadimastem - parameter.io Wed, 29 Oct 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for NLSP
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|